HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Po-Li Wei Selected Research

Hormones (Hormone)

1/2023In silico analysis to identify miR-1271-5p/PLCB4 (phospholipase C Beta 4) axis mediated oxaliplatin resistance in metastatic colorectal cancer.
6/2014Thrombomodulin mediates the migratory ability of hormone-independent prostate cancer cells through the regulation of epithelial-to-mesenchymal transition biomarkers.
3/2011Tea polyphenol (-)-epigallocatechin-3-gallate inhibits nicotine- and estrogen-induced α9-nicotinic acetylcholine receptor upregulation in human breast cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Po-Li Wei Research Topics

Disease

69Neoplasms (Cancer)
12/2023 - 11/2003
29Neoplasm Metastasis (Metastasis)
12/2023 - 06/2009
20Colorectal Neoplasms (Colorectal Cancer)
01/2024 - 01/2016
19Colonic Neoplasms (Colon Cancer)
06/2020 - 06/2009
17Hepatocellular Carcinoma (Hepatoma)
01/2021 - 05/2009
9Breast Neoplasms (Breast Cancer)
05/2023 - 09/2010
8Rectal Neoplasms (Rectal Cancer)
01/2023 - 05/2012
8Carcinogenesis
02/2022 - 09/2010
5Stomach Neoplasms (Stomach Cancer)
07/2016 - 09/2011
5Appendicitis
06/2014 - 04/2004
5Morbid Obesity
11/2006 - 12/2002
3Postoperative Pain
05/2024 - 09/2018
3Wounds and Injuries (Trauma)
10/2018 - 06/2004
3Pain (Aches)
09/2018 - 09/2003
3Weight Loss (Weight Reduction)
05/2005 - 12/2003
2Hemorrhoids
05/2024 - 09/2018
2Pathologic Constriction (Stenosis)
05/2024 - 08/2022
2Triple Negative Breast Neoplasms
12/2023 - 02/2018
2Lymphatic Metastasis
10/2023 - 12/2016
2Infections
01/2022 - 06/2013
2Inflammation (Inflammations)
01/2019 - 01/2014
2Hyperlipidemias (Hyperlipidemia)
09/2018 - 12/2003
2Carcinoma (Carcinomatosis)
03/2015 - 04/2006
2Hernia (Hernias)
11/2010 - 07/2006
2Liver Neoplasms (Liver Cancer)
05/2009 - 05/2009
1Hemorrhage
05/2024
1Postoperative Hemorrhage
05/2024
1Malaria
01/2023

Drug/Important Bio-Agent (IBA)

17Proteins (Proteins, Gene)FDA Link
10/2023 - 02/2010
10Small Interfering RNA (siRNA)IBA
03/2015 - 06/2009
9Biomarkers (Surrogate Marker)IBA
03/2021 - 01/2014
9Endoplasmic Reticulum Chaperone BiPIBA
06/2015 - 02/2010
8Glucose (Dextrose)FDA LinkGeneric
06/2015 - 02/2010
7CateninsIBA
01/2023 - 01/2017
7MicroRNAs (MicroRNA)IBA
03/2021 - 10/2013
7NicotineFDA Link
07/2016 - 09/2010
6CurcuminIBA
05/2023 - 08/2011
6VimentinIBA
01/2019 - 01/2012
6Cholinergic ReceptorsIBA
07/2016 - 06/2009
6Messenger RNA (mRNA)IBA
01/2016 - 05/2009
5ThrombomodulinIBA
12/2023 - 01/2014
5Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2023 - 01/2016
5glucose-regulated proteinsIBA
01/2021 - 04/2016
4Fluorouracil (Carac)FDA LinkGeneric
06/2020 - 01/2017
4SurvivinIBA
10/2014 - 01/2012
4Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
07/2012 - 09/2010
3Estrogen ReceptorsIBA
05/2023 - 09/2011
3Estrogens (Estrogen)FDA Link
05/2023 - 03/2011
3Hormones (Hormone)IBA
01/2023 - 03/2011
3InterleukinsIBA
06/2020 - 03/2015
3Interleukin-6 (Interleukin 6)IBA
06/2020 - 01/2017
3ovatodiolideIBA
01/2020 - 01/2017
3Fibronectins (Fibronectin)IBA
01/2016 - 06/2011
3Cadherins (E-Cadherin)IBA
03/2015 - 06/2009
3alpha7 Nicotinic Acetylcholine ReceptorIBA
07/2012 - 06/2009
3CarcinogensIBA
07/2012 - 06/2009
2RNA (Ribonucleic Acid)IBA
06/2023 - 03/2016
2Aldehyde DehydrogenaseIBA
01/2023 - 01/2022
2Bromelains (Bromelain)IBA
01/2023 - 01/2019
2ErbB Receptors (EGF Receptor)IBA
02/2022 - 06/2020
2Cetuximab (Erbitux)FDA Link
02/2022 - 01/2016
2Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
02/2022 - 03/2015
2Epidermal Growth Factor (EGF)IBA
01/2022 - 03/2021
2Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2020 - 08/2017
2Drug CombinationsIBA
01/2019 - 01/2017
2HSP27 Heat-Shock ProteinsIBA
12/2018 - 09/2018
2CytokinesIBA
09/2018 - 01/2017
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2018 - 11/2013
2Bevacizumab (Avastin)FDA Link
01/2018 - 12/2012
2IntegrinsIBA
01/2018 - 01/2016
2Thyroid HormonesIBA
01/2018 - 01/2016
24- (N- methyl- N- nitrosamino)- 1- (3- pyridyl)- 1- butanoneIBA
07/2012 - 06/2009
2DNA (Deoxyribonucleic Acid)IBA
06/2011 - 06/2009
1Sitagliptin Phosphate (Januvia)FDA Link
01/2024
1moesinIBA
06/2023
1Protein Kinases (Protein Kinase)IBA
06/2023
1Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA
06/2023
1SteroidsIBA
01/2023
1AntigensIBA
01/2023
1EpitopesIBA
01/2023
1Phospholipase C betaIBA
01/2023

Therapy/Procedure

22Therapeutics
06/2023 - 05/2012
11Drug Therapy (Chemotherapy)
01/2023 - 04/2004
5Length of Stay
08/2022 - 09/2003
5Appendectomy
06/2014 - 04/2004
4Gastric Bypass (Roux-en-Y Gastric Bypass)
07/2006 - 05/2005
3Operative Time
05/2024 - 05/2009
3Lasers (Laser)
05/2024 - 05/2009
3Radiotherapy
01/2023 - 08/2020
3Bariatric Surgery
07/2006 - 12/2003
2Hemorrhoidectomy
05/2024 - 09/2018
2Robotic Surgical Procedures
08/2022 - 06/2019
2Chemoradiotherapy
01/2020 - 09/2016
2Laparotomy
06/2019 - 04/2006
2Neoadjuvant Therapy
10/2017 - 05/2012
2Colectomy
08/2015 - 04/2004
2Herniorrhaphy
10/2012 - 07/2006
2Operative Surgical Procedures
11/2010 - 05/2009
2Surgical Instruments (Clip)
07/2006 - 06/2004
1Semiconductor Lasers
05/2024